- Report
- November 2023
- 175 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- December 2023
- 140 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- January 2023
- 154 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- April 2022
- 120 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- July 2021
- 112 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- December 2023
- 150 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- January 2022
- 176 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- July 2023
- 145 Pages
Global
From €2985EUR$3,150USD£2,519GBP
- Report
- September 2023
- 115 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- May 2023
- 120 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- April 2023
- 140 Pages
Global
From €4690EUR$4,949USD£3,958GBP
- Report
- April 2023
- 147 Pages
Global
From €4690EUR$4,949USD£3,958GBP
- Report
- April 2023
- 147 Pages
Global
From €4690EUR$4,949USD£3,958GBP
- Report
- December 2023
- 231 Pages
Global
€4733EUR$4,995USD£3,995GBP
- Drug Pipelines
- March 2021
Global
From €1895EUR$2,000USD£1,599GBP
- Report
- October 2023
- 146 Pages
Global
From €3343EUR$3,528USD£2,821GBP
€3933EUR$4,150USD£3,319GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4643EUR$4,900USD£3,919GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4643EUR$4,900USD£3,919GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4643EUR$4,900USD£3,919GBP
- Report
- August 2023
- 300 Pages
Europe
From €4643EUR$4,900USD£3,919GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more